Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03115788 · ClinicalTrials.gov registry record · NA

Pain Effect on Attention Using an Ipad Game App

A NA study of Cognitive Function, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT03115788: Completed NA study of Cognitive Function, sponsored by Wake Forest University Health Sciences.

NCT03115788 is a NA study of Cognitive Function that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 12 participants, below the 497-participant average among 20 other Cognitive Function trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03115788, a NA study of Cognitive Function, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Cognitive performance will be studied over time using an iPad game interface called the nine choice human game (5CH) in normal volunteer subjects before during and after experimentally induced thermal (cold or warm) pain or control (no intervention).

Primary Outcome

ipad game performance

Conditions Studied

Interventions

  • OTHER iPad
  • OTHER Heat induced pain
  • OTHER Cold Induced Pain

Study Locations (1)

North Carolina

  • Wake Forest University School of Medicine - Winston-Salem

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2016-05-15
Est. Completion 2025-07-01
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT03115788 record still lists

NCT03115788 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 497-participant average among 20 other Cognitive Function trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Cognitive Function appearing as the primary indexed condition, and to 3 interventions - of which iPad is the first listed.

NCT03115788 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03115788 about?

NCT03115788 is a clinical study titled "Pain Effect on Attention Using an Ipad Game App". Cognitive performance will be studied over time using an iPad game interface called the nine choice human game (5CH) in normal volunteer subjects before during and after experimentally induced thermal (cold or warm) pain or control (no intervention).

What is the current status of trial NCT03115788?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-05-15. Estimated completion is 2025-07-01.

What conditions does trial NCT03115788 study?

This clinical trial studies the following conditions: Cognitive Function.

What interventions are being tested in trial NCT03115788?

The interventions under investigation include: iPad (OTHER), Heat induced pain (OTHER), Cold Induced Pain (OTHER).

Who is sponsoring clinical trial NCT03115788?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03115788 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03115788's enrollment target sits among peer trials

12 20th of 20 higher than 1 of 20 other Cognitive Function trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Function trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03115788, the US trial registry maintained by the National Library of Medicine. NCT03115788 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.